Enliven Therapeutics Inc (ELVN)
Investing Cash Flow
-$390.72M
TTM · Period ending: · USD
ELVN Investing Cash Flow
Latest reported-$390.72Mperiod ending
Latest reported-$390.72Mperiod ending
ELVN TTM Cash from Investing (-$24.06M → -$390.72M)
TTM investing cash flow
High-resolution chart · PNG
ELVN investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -390,719,000 | |
| -132,742,000 | |
| -173,841,000 | |
| -185,493,000 | |
| -166,609,000 | |
| -16,685,000 | |
| -35,997,000 | |
| 1,962,000 | |
| -48,413,000 | |
| -166,266,000 | |
| -148,412,000 | |
| -187,199,000 | |
| -151,664,000 | |
| -449,000 | |
| -612,000 | |
| -15,002,000 | |
| -23,820,000 | |
| -20,129,000 | |
| -1,632,000 | |
| 34,071,000 | |
| 32,621,000 | |
| -3,175,000 | |
| -16,721,000 | |
| -40,045,000 | |
| -51,630,000 | |
| -19,303,000 | |
| -24,060,000 |